Author

Wenqing Su

Observed names: W. Su, Wenqing, Su

Observed institutions: Huazhong Agricultural University, Jazz Pharmaceuticals (United States), Peking University People's Hospital

ORCID: 0009-0008-3724-6385

Observed ORCID: 0009-0008-3724-6385

OpenAlex ID: A5101751383

RNA sequencing provides insights into the evolution of lettuce and the regulation of flavonoid biosynthesis

2017 · Lei Zhang, Wenqing Su, et al. · Nature Communications · 191

Characterization of four polymorphic genes controlling red leaf colour in lettuce that have undergone disruptive selection since domestication

2019 · Wenqing Su, Rong Tao, et al. · Plant Biotechnology Journal · 99

Validation of a one-step genomics-based molecular classifier for endometrial carcinoma in a large Chinese population

2024 · Nan Kang, Xiaobo Zhang, et al. · Pathology - Research and Practice · 22

Real-World Treatment Patterns Among Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) Who Initiated an Asparaginase Treatment after the Approval of Recombinant Erwinia (Rylaze)

2023 · Luke Maese, Helen Latimer, et al. · Blood · 2

Immune activation-related risk score: A new tool to predict prognosis and immunotherapy applicability in colorectal cancer.

2023 · Changbin Zhu, Wenqing Su, et al. · Journal of Clinical Oncology · 1

CXCL1 and CXCL8: Reliable and feasible biomarkers differentiating intrapulmonary metastasis from multiple primary neoplasms in non-small cell lung cancers

2025 · Ao Liu, Tianlin Sun, et al. · Cancer Biomarkers

Abstract 1035: Identification of fibroblast growth factor receptors (FGFRs) alterations (alts) at DNA and RNA-level by one-step next-generation sequencing (NGS) panel

2024 · Min Qing, Xuejun Chen, et al. · Cancer Research

159P Better performance of pan-claudin18 antibodies on claudin18.2 detection in gastric adenocarcinoma than claudin18.2 specific antibody

2023 · S. Ni, W. Sheng, et al. · Annals of Oncology

110P Detection of HER2 overexpression in biliary tract cancers: Comparison of AmoyDx® HER-2 (29D8) assay with ventana PATHWAY anti-HER-2/neu (4B5) assay

2023 · H. Dong, W. Su, et al. · Annals of Oncology

Determining MSI status by a one-step PCR melting curve analysis of Chinese-specific mononucleotide repeats.

2023 · Huang Chen, Jianzheng Jie, et al. · Journal of Clinical Oncology

Molecular Classification of Endometrial Cancer of Chinese Population

2022 · Nan Kang, Xiaobo Zhang, et al. · Research Square

Analysis of genomic alterations in pan-cancer from a large real-world Chinese population.

2022 · Zhouhuan Dong, Jie Gao, et al. · Journal of Clinical Oncology

Molecular classification of endometrial cancer of Chinese population.

2022 · Nan Kang, Zhiqi Wang, et al. · Journal of Clinical Oncology

Works count: 14

Citation count: 315

H-index: 3

I10-index: 3